AAV is a rare and severe multisystem disease affecting the small arteries.1,2 The condition is characterised by systemic inflammation across multiple body sites including the lungs, joints, kidneys, nerves, ears, and nose.1,2 Glucocorticoids and immunosuppressants form the cornerstone of current treatment approaches.

The COVID-19 outbreak, first identified in the Wuhan district of China in December 2019, was declared a pandemic by the World Health…

LACK of diversity in pancreatic cancer clinical trials means that many minority patients remain conspicuously absent from consideration…

Busada’s study focused on testosterone, the primary male sex hormone, but also investigated glucocorticoids, steroid hormones with…

One of my first ‘house jobs’ was in cardiology, in a District General Hospital, with two great Consultants, one male and one female…

THE EUROPEAN Society of Cardiology (ESC) Congress 2021 successfully brought together clinicians and researchers from across the globe…

Patients with HF embark on a vicious cycle characterised by progressive worsening over time, recurrent hospitalisations associated…

The clinical syndrome of paroxysmal supraventricular tachycardia (PSVT) is characterised by recurrent, acute episodes of rapid heart rate…

Psoriasis has been associated with vascular and myocardial dysfunction through mechanisms of inflammation and oxidative stress…